Relationships between serum unsaturated fatty acids and coronary risk factors. Negative relations between nervonic acid and obesity-related risk factors

International Heart Journal

Volumn 46, Issue 6, 2005, Pages 975-985

  Oda, Eiji ^a   Hatada, Katsuharu ^b   Kimura, Jun ^b   Aizawa, Yoshifusa ^b   Thanikachalam, Punniyakoti Veeraveedu ^c   Watanabe, Kenichi ^c  

^a Niigata Prefectural Yoshida Hospital   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Diabetes mellitus; Leptin; Metabolic syndrome; Obesity

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LEPTIN; LINOLEIC ACID; OLEIC ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; 15 TETRACOSENOIC ACID; MONOUNSATURATED FATTY ACID;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; MALE; METABOLIC DISORDER; MULTIPLE REGRESSION; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; EICOSAPENTAENOIC ACID; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LEPTIN; LINOLEIC ACID; MALE; MIDDLE AGED; OBESITY; OLEIC ACID; REGRESSION ANALYSIS; RISK FACTORS;

EID: 30444432363     PISSN: 13492365     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.46.975     Document Type: Article

References (42)

1. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003; 108: 1541-5. (Review)
2. Wolfram G. Dietary fatty acids and coronary heart disease. Eur J Med Res 2003; 20: 321-4. (Review)
3. Jonsson S, Hedblad B, Engstrom G, Nilsson P, Berglund G, Janzon L. Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes Relat Metab Disord 2002; 26: 1046-53.
4. Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104: 3052-6.
5. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. seven Countries Study Research Group. N Eng J Med 2000; 342: 1-8.
6. Sharret AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-1 and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104: 1108-13.
7. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-40.
8. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-25. (Review)
9. Oda E, Hatada Y, Katoh K, Kodama M, Nakamura Y, Aizawa Y. A case-control pilot study on n-3 polyunsaturated fatty acid as a negative risk factor for myocardial infarction. Int Heart J. (in press)
10. Kris-Etherton PM, Hecker KD, Binkoski AE. Polyunsaturated fatty acids and cardiovascular health. Nutr Rev 2004; 62: 414-26. (Review)
11. Bemelmans WJ, Broer J, Feskens EJ, et al. Effect of an increased intake of α-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am J Clin Nutr 2002; 75: 221-7.
12. Djousse L, Hunt SC, Arnett DK, Province MA, Eckfeldt JH, Ellison RC. Dietary linolenic acid is inversely associated with plasma triacylglycerol: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2003; 78: 1098-102.
13. Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004; 134: 2991-7.
14. Ma J, Folsom AR, Shahar E, Eckfeldt JH. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Clin Nutr 1995; 62: 564-71.
15. Wang L, Folsom AR, Eckfeldt JH. Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Nutr Metab Cardiovasc Dis 2003; 13: 256-66.
16. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxizome proliferator-activated receptors α and δ. Proc Natl Acad Sci USA 1997; 94: 4312-7.
17. Kliewer SA, Sundseth SS, Jones SA, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc Natl Acad Sci USA 1997; 94: 4318-23.
18. Kris-Etherton PM, Harris WS, Appel LJ. American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-57.
19. Leaf A, Kang JX, Xiao Y, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003; 107: 2646-52.
20. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 2003; 361: 477-85.
21. Pepe S, McLennan PL. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 2002; 105: 2303-8.
22. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999; 70 (3 Suppl): 560S-9. (Review)
23. Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J. Interactions between dietary fat, fish and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arteroscler Thromb Vasc Biol 1997; 17: 279-86.
24. 2+-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett 2001; 487: 361-6.
25. 2+ sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway. Circ Res 2002; 91: 953-60.
26. Wijendran V, Hayes KC. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 2004; 24: 597-615. (Review)
27. Brady LM, Lovegrove SS, Lesauvage SV, et al. Increased n-6 polyunsaturated fatty acids do not attenuate the effects of long-chain n-3 polyunsaturated fatty acids on insulin sensitivity or triacylglycerol reduction in Indian Asians. Am J Clin Nutr 2004; 79: 983-91.
28. Mozaffarian D, Ascherio A, Hu FB, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005; 111: 157-64.
29. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346: 1113-8.
30. Marchioli R, Barzi F, Bomba. E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-903.
31. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol 1995; 25: 387-94.
32. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002; 112: 298-304.
33. Tavani A, Pelucchi C, Negri E, Bertuzzi M, La Vecchia C. N-3 Polyunsaturated fatty acids, fish, and nonfatal acute myocardial infarction. Circulation 2001; 104: 2269-72.
34. Siscovick DS, Lemaitre RN, Mozaffarian D. The fish story: a diet-heart hypothesis with clinical implications: n-3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death. Circulation 2003; 107: 2632-4.
35. Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 1980; 33: 2657-61.
36. Sargent JR, Coupland K, Wilson R. Nervonic acid and demylinating disease. Med Hypotheses 1994; 42: 237-42.
37. Sandhir R, Khan M, Chahal A, Singh L. Localization of nervonic acid beta-oxidation in human and rodent peroxisomes: impaired oxidation in Zellweger syndrome and X-linked adrenoleukodystrophy. J Lipid Res 1998; 39: 2161-71.
38. Lecerf J. Evidence of accumulation of ceramides containing [14C] nervonic acid in the rat lung following injection of [14C] erucic acid. Biochim Biophys Acta 1980; 617: 398-409.
39. Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 1975; 28: 958-66.
40. Beare-Rogers JL. Docosenoic acids in dietary fats. Prog Chem Fats Other Lipids 1977; 15: 29-56. (Review)
41. Bremer J, Norum R. Metabolism of very long-chain monounsaturated fatty acids (22:1) and the adaptation to their presence in the diet. J Lipid Res 1982; 23: 243-56. (Review)
42. Ackman RG, Eaton CA, Dyerberg J. Marine docosenoic acid isomer distribution in the plasma of Greenland Eskimos. Am J Clin Nutr 1980; 33: 1814-7.